Free Trial

Glanbia (LON:GLB) Stock Price Crosses Above Fifty Day Moving Average - Here's Why

Glanbia logo with Consumer Defensive background

Key Points

  • Glanbia plc shares crossed above their 50-day moving average, indicating potential bullish momentum as the stock traded as high as GBX 13.20 ($0.17).
  • Insider Thomas Phelan purchased 1,558 shares at an average price of GBX 1,151 ($15.20), suggesting insider confidence in the company's future.
  • Glanbia has a market capitalization of £3.34 billion and a debt-to-equity ratio of 48.90, reflecting its financial health and leverage.
  • Five stocks to consider instead of Glanbia.

Glanbia plc (LON:GLB - Get Free Report)'s stock price crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 12.70 ($0.17) and traded as high as GBX 13.20 ($0.18). Glanbia shares last traded at GBX 12.89 ($0.17), with a volume of 7,141 shares.

Glanbia Stock Down 4.5%

The company's 50 day moving average price is GBX 12.72 and its 200 day moving average price is GBX 12.13. The company has a quick ratio of 0.86, a current ratio of 1.63 and a debt-to-equity ratio of 48.90. The firm has a market capitalization of £3.21 billion, a price-to-earnings ratio of 25.00, a P/E/G ratio of 8.32 and a beta of 0.47.

Insider Activity at Glanbia

In other Glanbia news, insider Thomas Phelan bought 1,558 shares of the firm's stock in a transaction that occurred on Monday, May 12th. The stock was bought at an average cost of GBX 1,151 ($15.28) per share, for a total transaction of £17,932.58 ($23,811.69). Insiders own 30.55% of the company's stock.

About Glanbia

(Get Free Report)

We are a better nutrition company, home to consumer brands and ingredients that help people around the world feel strong, nourished, and to perform well at any age. Everything we do has real nutritional benefit. Everything we do is in pursuit of better, for each other and the planet.

Recommended Stories

Should You Invest $1,000 in Glanbia Right Now?

Before you consider Glanbia, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Glanbia wasn't on the list.

While Glanbia currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines